chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Nausea, vomiting, dizziness, mental fog. Dizziness and mental fog lasted 3 days. Severe pain in arm for about 3 hours, a few hours after the shot.
Redness, heat, pain at site.  Also "startled" awake numerous times throughout the night and was momemtarily disoriented.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 08-AUG-2011, the patient was administered with a dose of VARIVAX (merck) (Lot # 1615162, expiry date unknown) (Route, dosing regimen and frequency unknown) which was exposed to a temperature excursion of up to -3 degrees Centigrade. No adverse events were reported. No product quality issue was reported. This is one of 121 reports received from the same source. Additional information has been requested.
This spontaneous report was received from a consumer who was the mother of a 17 year old female patient. No medical history and concomitant medications were reported. Approximately in 1998 (reported as around 12 months of age), the patient was vaccinated with M-M-R II (Strength, dose, route, lot # were not provided). Other suspect therapies included DTAP (brand, dose, manufacturer not specified). The reporter stated that she believed her daughter's diagnosis of "autism" not long after the administration of the M-M-R II and DTAP was the result of the "cocktail" of vaccinations given concomitantly. Patient sought medical attention through office visits. The patient's status was, she was diagnosed as "Autistic". No further symptoms were provided. No product quality complaint was involved. The outcome of "autism" was unknown. Causality assessment was not provided. Additional information has been requested.
a tender lump under my left arm in my armpit; Chills; headache; tiredness; This is a spontaneous report from a contactable consumer for himself. A 44-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 23Feb2021 10:30 (Lot number: EL3247) via an unspecified route of administration in the left arm at SINGLE DOSE for COVID-19 Immunization at workplace clinic. The patient had no medical history and not had allergies to medications, food, or other products. The patient's concomitant medications were not reported. The patient had first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 03Feb2021 14:30 (Lot number: EL3247) via an unspecified route of administration in the left arm at SINGLE DOSE for COVID-19 Immunization. The patient has not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient has not taken any other medications within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 prior to vaccination and was not tested for COVID-19 since vaccination. The patient experienced chills, headache, tiredness the second morning after the second dose administered on 23Feb2021 the patient noticed a tender lump under his left arm in armpit on 25Feb2021 06:45. The reporter assessed the events as non-serious. The patient has not received treatment. The outcome of the event was not recovered.  No follow-up attempts are possible. No further information is expected.
Woke in the night with coughing that led to vomiting, followed by a temperature reading of 100.4 F rectal.  I am having mother continue to monitor temperature and other sx, thought patient is behaving normally today.
In August or September, I began having chest pain. I am also having frequent headaches, nausea, and back pain through the back of my chest.
Morning following vaccination developed warmth and erythema at injection site that progressed to edema increasing erythema and cellulitis. 8-27-07 Prescribed Augmentin ES due to worsening symptoms.
Abdominal upset, bloating, nausea, sharp severe pain in lower back/kidney area, disorientation, unable to forms thoughts, feverish, shivers, headache and unusally tired.
Headache, Sedation, Myalgia, Arthralgia, Fever NauseaVomiting CHILLS, RIGORS, ENLARGED TENDER ARM LYMPH NODES INTENSE BONE AND BACK PAIN Narrative:  Other Relevant History:
Developed rash/skin colored bumps 10 minutes after receiving hepatitis B vaccine in left upper arm. Developed similar rash in right arm within 20 minutes. No respiratory problems. Rash lasted 3 days. Also had a headache/agitation for 1 hour, 3 hours after shot.
Wrong dose for age  of child.  Mother preferred 5 year old receive 2nd Pfizer as a 6mo-4 year dose ( 3mg/ 0.2 ml ) dose. Mother reports that child was lethargic for now day after  dose 1 Pfizer dose for 5 y-11y ( 10mg/0.2 ml) dose was received.  NP consult w/ PCHD physician regarding parental choice. Mother understands that this dose of un authorized vaccine may not provide adequate immunity. VAERS filed to report this parental choice.  No reported adverse side effects
bladder infection; This is a spontaneous report from a Pfizer-sponsored program. A 79-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247), dose 1 via an unspecified route of administration on 14Jan2021 (at the age of 79-years-old) as dose 1, single for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient had her first covid-19 vaccine 2 weeks ago. The patient experienced bladder infection last week (on 2021). She was seen by her doctor last Friday. Her second dose scheduled, and she was inquiring if she should have her second dose of the covid-19 vaccine today on 08Feb2021. Her husband was asking if it ok to take shot with the vaccine with being on an antibiotic. Her husband does not feel the vaccine caused the bladder infection. She was currently taking Unspecified antibiotic the last 2 weeks. The outcome of the event was unknown.   Follow-up attempts completed. No further information expected.
The pt had chills, fever (103F) and 5" diameter of redness around the injection site.
Received vaccine at approximately 1440 on 12/3/21. Began experiencing itching in the inguinal region at approximately 0000 on 12/4/21. Went to sleep and was awoken around 0515 with severe itching with large hives in the bilateral axillary, neck, and inguinal areas. Took 10mg loratadine po and applied 1% diphenhydramine cream to the affected areas. Reassessed around 0730 on 12/4/21; areas were slightly improved but symptoms persisted so redosed  with another 10mg loratadine po and 1% diphenhydramine cream topically to affected areas. Symptoms waxed and waned throughout the day; took another 10mg loratadine po around 1930. Nausea and chills were also present throughout this time although no specific pharmacologic intervention was made for these symptoms. symptoms.
April 13, 2021 at approximately 9am I started passing blood clots,   April 16,2021 blood clots stopped and I have not had any more.  It felt as though I was having a period , except the blood clots were coming from my rectom.
Hospitalization for bilateral pneumonia likely due to COVID-19 on dates 10/5/22- 10/21/22.  Treated with dexamethasone, baricitinib, vitamin C 1,000 mg PO daily, vitamin D 25 mcg PO daily, zinc 50 mg PO daily.
An itchy and sometimes tingly swollen welt/rash at the location of the injection. Firm to touch and about an inch and a half in diameter.  Additionally a swollen lymph node along the collarbone.
3/16/08 Redness, itching, area of imm. swollen (R) arm. 3/17/08 Red area (R) arm baseball size - itching - no swelling - warm to touch.
Local inflammatory reaction. 7x7 warm erythematous area assoc w/ persist fever. DX cellulitis, secondary to sterile abscess from DTap vax.
Patient was given the second dose of monkeypox vaccine that had expired 8/31/2023. No symptoms reported.
Have had sniffles and a scratchy throat with dry cough. Symptoms usually associated with a cold. Unsure if related to vaccine, but haven't been around anyone sick.
Patient presented to ED 2/6/21 with rash on abdomen/chest with pruritus for past 1 day. Denies nausea/vomiting, chest pain, dyspnea, dizziness, cough. Received COVID vaccine and also prescribed Bactrim on 2/4/21. Also presented with acute renal failure, hyponatremia. It is likely that all these events are due to Bactrim but we are reporting to VAERS given patient received vaccine at same time. Patient has been treated with hydration with normal saline, Solu-Medrol, Pepcid, and cetirizine, Calamine lotion, sodium chloride tablets. Symptoms of rash have improved and sodium is improving.
From 11 PM the day of the shot until suppertime of the next day, I felt absolutely horrible all over my body.  I had chills, my teeth were chattering, and I was very weak and scared to get out of bed for fear of falling down.  I had never felt so bad, even with flu.  I took Tylenol, and that did no good, so I took Ibuprophen along with it 3 separated times, and that made me feel better.  The day after the shot I took my temperature and it was 99.6 an hour after the Tylenol 6 hour dose period.  I usually have low temperatures like 95-97, so this was really high for me.  That night after supper I was able to stay up and watch TV, so I was starting to feel better.  I was very tired the next day.  I called no doctor..  I should add that I am a small person, 4 ft. 11 inches, and 116 pounds.
Patient to advised she was given two doses in her vaccine yesterday;  Received a double dose of pfizer vaccine.
This spontaneous report as received from a 63 years old female patient with sulfa drug allergy and computed tomography (CT) scan iodine allergy. The patient's medical history included colon cancer (5 years ago in 2009). On 02-AUG-2014, also reported as two weeks ago, the patient was vaccinated with the first dose (one time vaccine) ZOSTAVAX (injection, lot # and expiry date were not reported). There was no concomitant therapy. On  14-AUG-2014, reported as last night, the patient noticed in the mirror that she had pinkish color around injection site with pin paint bruise at center where the needed went in it was reported that blood test and urine test were performed 4 months ago as a part of follow up for her cancer (April 2014). It was reported that the patient did not seek medical attention. The outcome of pinkish color around injection site with pin point little bruise at center where the needed went in was not reported. The relatedness between ZOSTAVAX and pinkish color around injection site with pin point little bruise at center where the needle went in was not reported.  Additional information has been requested.
Mom called because she received flu shot on Tuesday and on Wednesday she had a baseball sized welt that was warm to the touch.  She hadn't been with her the past couple of days but upon seeing her on Friday, she states the swelling has moved to the back of her arm and is still warm to touch.  Vaccine reaction: seen in office, swollen red arm.  Warm compress and alternate Tylenol and Motrin every 4 hours.
Pt recv vax on 9/8/98; on 9/9/98 pt exp irritation, unconsolable high pitched cry, difficulty feeding, not sleeping well
Received DTaP 9/4/02. On 9/5/02, mom noticed left arm at DTaP site swollen and red. Clinic nurse reports area 5"x5" swollen and tight. No fever reported per mom. Child otherwise OK. Has been placed on Neosporin/warm compresses to area. 9/9/02 Mom reports child ok.
This spontaneous report as received from a physician refers to a female patient of unknown age. The patient was vaccinated with a 0.65 mL dose of ZOSTAVAX (lot # not reported) subcutaneously on an unknown date. On an unknown date the patient experienced "red welts down arm and a fever of 101 degrees". It was reported that the patient sought for unspecified medical attention and the patient was advised to take TYLENOL for fever. The outcome was reported as recovered. Additional information has been requested.
Constant nausea. I was in the ER for 13 hours. They did every scan, every blood work and every test imaginable trying to figure out what is wrong with me. Everything was completely normal. They only thing different is that I was vaccinated.
Diffuse erythematous indurated reaction from shoulder to elbow in the vaccinated arm (lt).  This reaction was mostly resolved within 3 days.
pt reported that was unable to lift arm w/in 7 hrs p/vax on 11FEB92; arm was red, swollen & hot to touch; required office visit on 13FEB; pt was able to lift arm-inject site reaction was improving; not cellulitis; no treatment initiated;
pt recvd vax 20JUL94 & broke out in rash all over body; Pt had some purpling w/rash exp prominent on legs; pt taken to MD 22JUL; devel fever late 22JUL; 23JUl (100.7) was treated only w/DPH & caladryl;
Pt was administered 1st dose of Pfizer Covid vaccine in right deltoid. A few minutes after while sitting in the observation area, she began to vomit.  BP 132/96 P 104 SpO2 98, 3 minutes later,  BP 161/106 P 119, SpO2 98. Pt has a hx of allergic reaction to coffee and MSG. ER notified. Pt was transported to  ER via wheelchair at 0915. Pt was in no acute distress, alert, oriented x3.
Patient felt heart pain within hours of receiving 2nd monovalent vaccine in the primary series; This is a spontaneous report received from non-contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A 39-year-old male patient received bnt162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid 19 vaccine (Manufacturer unknown, dose 1, not bivalent), for COVID-19 immunization. The following information was reported: ANGINA PECTORIS (medically significant), outcome "recovered", described as "Patient felt heart pain within hours of receiving 2nd monovalent vaccine in the primary series". Therapeutic measures were not taken as a result of angina pectoris.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient was supposed to receive the bivalent Pfizer booster shot.  By error, the patient received the monovalent Pfizer vaccine shot.
Approximately 9 days after injection, I became extremely itchy. I experienced widespread hives all over my body for 4 days. Benadryl was taken every 4 hours and provided minimal to zero relief. After 4 days, began taking Zyrtec (10mg/day) which quelled the hives but did not resolve dermatographia. It has now been three months and I am still taking 5mg/day Zyrtec and still experiencing daily dematographia and occasional hives. I've tried twice to stop taking the Zyrtec, but the symptoms come back within 48 hours.
The vaccine expiration date was identified to expire on June 22, 2021, but the manufacturer expiration date was February 25, 2021.  Based on the information learned, County Health took the following steps: ? Covid-19 Response Unit Pharmacists contacted Moderna for guidance and based on Moderna data, the Moderna Medical Information team provided the following information:  o ?The vaccine administered on March 4, 2021 through March 10, 2021 from lot number 025J20-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.?  o A county medical director was contacted and based on this information from Moderna, no re-vaccination is needed.
2 weeks after 2nd Pfizer covid shot; onset of Pityriasis rubra pilaris (PRP) starting at scalp and continuing to involve entire body.  Condition is highly acute, including  PRP typical symptoms of scaling of skin, inflammation of ankle and knee joints, deep red skin color, thickening of skin on palms and foot bottoms.
Patient received pneumococcal vaccine in his left arm and 4 hours later experienced swelling, hardness and pain at site. Pain increased through the night and experienced limited mobility due to pain. Swelling increased extending down to elbow so called office Friday - a dose pk to pharmacy. Pain and swelling decreased 2 hours after taking meds. Sx subsided within 2 days.
Patient given moderna booster (0.25 dose) after having Pfizer adult vaccine 8/20/2022. No adverse symptoms/reactions currently.
patient had a rash at vaccination admin site starting  august 14 , rapid heart beat, high blood pressure, shortness of breath, overall weakness
Information has been received from a licensed practical nurse and a consumer concerning a 12 year old female twin who on an unspecified date was vaccinated with the first dose of VARIVAX (Oka/Merck) and was well tolerated. On 06-AUG-2008, was vaccinated with the second dose of VARIVAX (Oka/Merck) (Lot # 661445/0525x). On 06-AUG-2008, received the fifth dose of ADACEL (Lot # C2995AA), a dose of VAQTA (LOT # AHAVB243AA OKA/MERCK) and a dose of GARDASIL (lot # 659435/1265U OKA/MERCK) and a dose of (LOT # 4254AA MENACTRA). On 07-AUG-2008, the patient experienced redness, itching and swelling at the injection site. The patient may have also experienced fever and/or pain and burning while getting injected with the vaccine. On 09-AUG-2008, the patient recovered. The reporter has requested a lot check due the vaccine. On 09-AUG-2008, the patient recovered. The reporter has requested a lot check due the patients having adverse experiences. The patient sought medical attention by calling the office. A standard lot check investigation was performed. All in-process quality checks for the lot number in question were satisfactory. The met the requirements of the government and was released. This is one of several reports provided by the same source. The patient's twin also experienced adverse events (WAES# 0808USA03477). No additional information is expected.
Information has been received from a physician concerning a 16-year-old black female student, who on 12/18/1997 was vaccinated in the right arm with the first dose of varicella virus vaccine live (Oka/Merck). The physician reported that in the middle of November 2005, the patient developed breakthrough chickenpox characterized by 20 varicella lesions on her body. The physician did not see the patient in her office, but unspecified attention was sought. At the time of this report, the outcome was unknown.
This spontaneous report as received from a healthcare worker refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients might have been vaccinated with improperly stored PROQUAD (Merck) (dose, frequency, route of administration, lot# and expiration date were not reported). No adverse events were reported. No product quality complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
Patient states that he started having body aches and soreness with weakness a day after the vaccination. later this progressed to red rash all over his body, rash looks like clusters of pimples with itching all over his body. He spoke with a nurse at his insurance who advised him to use benadryl oral and cortisone cream. So far it is getting worse so I advised him to go see a doctor.
The first shot I experienced a rapid heart rate and loss of use of my arm for a few days. I could not sleep for about 3 days. The second dose I also had heart palpitations and have had muscle weakness and trouble sleeping since.
swelling in arm; pain for a day; a little fatigue for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling in arm), PAIN (pain for a day) and FATIGUE (a little fatigue for 24 hours) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027B21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS, ALENDRONATE SODIUM (FOSAMAX) and DOXYCYCLINE for an unknown indication.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced PERIPHERAL SWELLING (swelling in arm), PAIN (pain for a day) and FATIGUE (a little fatigue for 24 hours). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. On 02-Apr-2021, PERIPHERAL SWELLING (swelling in arm), PAIN (pain for a day) and FATIGUE (a little fatigue for 24 hours) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment medication reported includes ADVIL.   This case was linked to MOD21-082758 (E2B Linked Report).; Sender's Comments:  MOD21-082758:
Chest pain began 6/18 with decrease in oxygen saturation.  Became unresponsive and subsequently expired in the afternoon of 6/18.
12 month old male patient administered expired dose of ActHib, with no adverse event; Initial information received on 28-Apr-2021 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 12 months old male patient who was administered expired dose of HIB (PRP/T) VACCINE [ACT-HIB] (expired product administered).  Medical history, medical treatment, vaccination and family history were not provided.  Concomitant medications included HEPATITIS A VACCINE INACT (HAVRIX) for Immunisation; PNEUMOCOCCAL VACCINE CONJ 13V (CRM197) (PREVNAR 13) for Immunisation; and MEASLES VACCINE LIVE (ENDERS-EDMONSTON), MUMPS VACCINE LIVE (JERYL LYNN), RUBELLA VACCINE LIVE (WISTAR RA 27/3) (MMR II) for Immunisation.  On 28-Apr-2021, the patient received a 0.5 ml dose of suspect HIB (PRP/T) VACCINE (Hib portion lot UJ136AA and expiry date: 05-Mar-2021, diluent vial lot U6574AA and expiry date: 25-Mar-2021) (Frequency: once) via an intramuscular route in the right thigh for prophylactic vaccination.  It was a case of actual medication error due to expired vaccine used (latency on same day).  It was also reported that the caller reported that ActHIB was administered to a patient today. The caller stated that the product expired on 05 MAR 2021. The caller would like know if the patient must be re-vaccinated and if there will be any potential adverse effects for the patient. Reporter relationship: health care professional (HCP) Product used: used still using product: no  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Headache (very strong): (Lasting 5 to 36 hours after injection).  Stomachache (sharp and stabbing): (5 to 24 hours after injection). Fever (low-grade, between 99 and 101): (5 to 36 hours after injection). Light sensitivity: (5 to 36 hours after injection). Dizziness: (5 to 36 hours after injection). Nausea: (24 to 36 hours after injection). Jaw pain: (24 to 72 hours after injection). Arm soreness (at site of injection): (5 to 72 hours after injection). Headache and fever were temporarily relieved (somewhat) by ibuprofen.
Nosebleed; nausea; muscle soreness; This is a spontaneous report from a contactable consumer (patient). A 29-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on an unspecified date (lot number was not reported) as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced nosebleed, nausea and muscle soreness on an unspecified date. The outcome of the events was unknown.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient noticed below her right ear was tender and swollen.  Pt states she still has about a 1.5 cm lump in the lymph node that is firm.  Pt states physician noticed some inflammation in the lymph nodes under both arm pits.